Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience

World Journal of Oncology- Canada

doi 10.14740/wjon1188

Full Text

Abstract

Available in

Date

Authors

Publisher

Elmer Press, Inc.

Related search

The Effect of Metastatic Focus on Survival After Cytoreductive Nephrectomy in Renal Cell Carcinoma: Experience of a Single Center

Acta Oncologica Turcica
2019English

Overall and Progression-Free Survival in Metastatic Melanoma: Analysis of a Single-Institution Database

Cancer Control
MedicineOncologyHematology
2006English

Extended Progression-Free Survival of Renal Cell Carcinoma With Axitinib: Case Report

Journal of Urology and Renal Diseases
2018English

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC)

PLoS ONE
Multidisciplinary
2015English

High Expression of HMGA2 Predicts Poor Survival in Patients With Clear Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Down-Regulation of TCF21 Is Associated With Poor Survival in Clear Cell Renal Cell Carcinoma

Neoplasma
Cancer Research
2012English

Prm155 - Joint Modeling of Overall Survival and Progression Free Survival

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Time on Therapy for at Least Three Months Correlates With Overall Survival in Metastatic Renal Cell Carcinoma

Cancers
Cancer ResearchOncology
2019English

Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions

Hematology/Oncology Clinics of North America
OncologyHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy